The Anitschkow Model Reconsidered: From Dietary Cholesterol to Disrupted Lipid Homeokinesis in Atherosclerosis

Mykola Iabluchanskyi and Pavlo Garkaviy

Abstract

The classical cholesterol‑fed rabbit model described by Nikolai Anitschkow

has long been interpreted primarily as an experiment in harmful dietary

cholesterol. In this narrow reading, atherosclerosis appears mainly as the

vascular consequence of excessive intake. A closer analysis, however,

suggests a richer meaning. The model shows what happens when an organism

is driven beyond the range in which lipid burden can still be processed,

redistributed, and cleared without long‑lasting disturbance of internal

regulation. In this sense, the Anitschkow rabbit is less a model of “bad diet”

and more a model of disrupted lipid homeokinesis and progressive lipid

accumulation with superimposed inflammation. This article argues that the

true conceptual value of the model lies in its demonstration of a transition

from externally imposed metabolic overload to an internally sustained

atherogenic state. Reinterpreted in this way, the model aligns more closely

with modern views of atherosclerosis as a disease of accumulation and as a

metabolic‑inflammatory process, and it offers a more relevant framework for

contemporary research, diagnosis, and treatment.

Introduction: a foundational model, but perhaps a narrowed reading

Few experimental systems have shaped the field of atherosclerosis as

profoundly as the cholesterol‑fed rabbit introduced by Nikolai Anitschkow.

By demonstrating that cholesterol feeding was sufficient to induce arterial

lesions in rabbits, Anitschkow helped establish hypercholesterolemia as a

causal driver of atherogenesis and gave experimental force to what later

became the lipid hypothesis. Yet the dominant legacy of this model may also

have narrowed its meaning. Read too literally, it encouraged a simplified

interpretation in which atherosclerosis appeared mainly as the vascular consequence 

of harmful dietary cholesterol, rather than as the failure of a complex endogenous 

system to maintain lipid equilibrium under stress.

This distinction matters. The scientific value of the Anitschkow model may

lie not only in showing that cholesterol can induce lesions, but in revealing

what happens when an organism is pushed beyond the homeokinetic range

within which lipid burden can still be safely processed, redistributed, and

cleared. Seen from this angle, the model does more than demonstrate the

impact of diet. It points toward a broader understanding of atherosclerosis as

a disorder of disrupted lipid homeokinesis, in which progressive lipid

accumulation is followed by a structured inflammatory and reparative

response in the arterial wall.

Why the dietary interpretation is incomplete

The traditional dietary reading of the Anitschkow model is incomplete for at

least three reasons.

First, the rabbit is a strict herbivore whose natural diet contains essentially no

meaningful cholesterol. This was recognized early as a legitimate criticism of

the model’s direct relevance to humans. The intervention was therefore not a

physiological nutritional challenge, but a radical metabolic provocation

imposed on an organism that was not evolutionarily adapted to handle it.

Second, dietary cholesterol does not act directly on the arterial wall as if it

were a simple external deposit. In both animals and humans, ingested

cholesterol enters a regulated network of intestinal absorption, intracellular

transport, hepatic handling, lipoprotein assembly, receptor‑mediated uptake,

excretion, and compensatory control of endogenous synthesis. Even in

humans, increased dietary cholesterol typically evokes counter‑regulatory

responses, including reduced synthesis and increased re‑excretion, although

these compensations vary markedly among individuals. The relevant

biological question, therefore, is not simply where the cholesterol came from,

but whether the organism’s internal regulatory systems can accommodate the

additional load without entering a self‑perpetuating pathological state.Third, 

the model does not behave like a simple exposure–toxin paradigm. If

cholesterol feeding were merely an external insult, one would expect

withdrawal of the diet to terminate the process relatively promptly. Yet this is

not what the experimental record shows. Plaques regress slowly after return

to normal chow, and in some studies convincing regression was not observed

even after prolonged dietary withdrawal. This persistence indicates that, once

an atherogenic state has been established, it cannot be explained solely by

continued external exposure. Internal lipid‑metabolic processes have been

shifted into a durable mode that favors continued lipid accumulation and

lesion maintenance.

The rabbit model as a model of disrupted lipid homeokinesis

Seen from this angle, the Anitschkow rabbit may be better understood as a

model of disrupted lipid homeokinesis rather than simply a model of harmful

diet. The key event is not the presence of cholesterol in the food itself, but the

inability of endogenous regulatory systems to absorb excessive lipid flux

while preserving metabolic stability. In that sense, the model exposes the

limits of the host system rather than merely the toxicity of the input.

The data after cessation of cholesterol feeding are especially informative. In

cholesterol‑fed rabbits returned to normal chow, aortic atheromatous plaques

regress only slowly, while hepatic production of cholesteryl ester‑rich VLDL

remains elevated and continues to deliver lipid to the arterial wall. This

finding is highly consequential. It implies that the pathological machinery of

lipid accumulation, once induced, can continue to operate even after the

original dietary stimulus has been withdrawn. The model therefore captures a

transition from external metabolic overload to internally sustained

atherogenic inertia.

This is precisely why the model may have broader conceptual value than is

usually acknowledged. It does not simply tell us that excessive cholesterol is

dangerous. It shows that atherosclerosis emerges when the organism fails to

maintain control over lipid burden and subsequently remains trapped in a

dysregulated metabolic state. In that respect, the model becomes conceptually

closer to persistent human dyslipidemic conditions, including severe inherited

disorders of lipoprotein handling, than to a simple narrative of dietary excess

alone. It supports the notion of atherosclerosis as a disease of lipid

accumulation that gradually acquires inflammatory and fibrotic components.

Atherosclerosis as a metabolic‑inflammatory response

This reinterpretation also allows a more precise formulation of the place of

inflammation in atherosclerosis. Contemporary literature often describes

atherosclerosis as a chronic inflammatory disease, and that description is

broadly justified. However, it can be misleading if it obscures the order of

events. Atherosclerosis is more accurately understood as a

metabolic‑inflammatory process in which disordered cholesterol handling and

lipid retention are primary, while chronic inflammation represents the

organism’s response to retained and modified lipid material within the arterial

wall.

In this view, inflammation is not an independent initiating principle but a

biological attempt to manage a problem that metabolism alone failed to

resolve. Lipid accumulation recruits monocytes and macrophages, promotes

foam‑cell formation, stimulates smooth muscle cell migration and

proliferation, and leads to extracellular matrix deposition and fibrous cap

formation. The plaque is therefore not merely a passive lipid deposit. It is an

organized tissue response that is at once compensatory and pathological,

aiming to isolate, stabilize, and contain material that the organism could not

adequately remove, but doing so at the cost of progressive structural

remodeling of the vessel wall.

This framework is particularly useful because it restores causal hierarchy. It

avoids the false alternative between “lipid disease” and “inflammatory

disease” by recognizing that the inflammatory component is embedded within

a prior failure of lipid homeokinesis and accumulation. The Anitschkow

model, reread in this way, becomes a model not simply of cholesterol

exposure, but of the metabolic conditions under which inflammatory

containment becomes structurally encoded in the arterial wall.

Implications for modern research, diagnosis, and treatment

If the Anitschkow model is reconsidered in these terms, its implications for

modern medicine are substantial.

For research, it suggests that a central task is not merely to quantify lipid

exposure but to define the thresholds, mechanisms, and phenotypes of failed

compensation. Why do some organisms or individuals accommodate

increased lipid burden with limited vascular consequences, while others enter

a state of persistent atherogenic dysregulation? This question—how and

when lipid accumulation escapes control—may be more important than the

older, simpler question of whether cholesterol is harmful.

For diagnosis, the implication is equally important. Risk assessment should

move beyond static lipid measurements alone toward detection of states of

metabolic vulnerability—whether inherited or acquired—in which

endogenous control of absorption, synthesis, transport, clearance, and

vascular handling is unstable. Familial hypercholesterolemia is the clearest

inherited example, but it is unlikely to be the only clinically relevant form of

metabolic incompetence. Acquired disturbances of lipid homeokinesis may

also exist in forms that are currently underdiagnosed or conceptually

undertheorized.

For treatment, the consequence is a shift in logic. If atherosclerosis reflects

disrupted lipid homeokinesis and progressive lipid accumulation rather than

merely harmful intake, then intervention should aim not only to reduce

exposure but to restore systemic control. This includes absorption,

endogenous synthesis, lipoprotein clearance, and the vascular response to

retained lipid. Such a framework also favors earlier intervention in

individuals whose metabolic regulation appears fragile, before irreversible

vascular remodeling and clinical events occur.

More broadly, this reading may open a new translational agenda: to classify

patients not only by lipid concentration or plaque burden, but by the degree to

which their atherogenic process is externally driven, internally sustained,

compensatorily contained, or metabolically inertial. That would mark a meaningful 

shift from descriptive dyslipidemia toward mechanistic stratification of 

atherosclerotic disease.

Conclusion

The Anitschkow model should be reconsidered not simply as the classic

demonstration that dietary cholesterol can induce atherosclerosis, but as a

deeper model of disrupted lipid homeokinesis under non‑physiological stress.

Its enduring significance may lie less in the claim that harmful diet causes

vascular disease than in the recognition that atherosclerosis begins when

endogenous systems of lipid regulation can no longer absorb, redistribute,

and neutralize metabolic burden without entering a persistent pathological

state of lipid accumulation and inflammatory remodeling.

Under this interpretation, atherosclerosis is best understood as a

metabolic‑inflammatory response to failed lipid handling, not as a primary

inflammatory disorder and not as a simple dietary lesion. The translational

implication is clear: modern medicine should focus not only on lipid

exposure, but on identifying inherited and acquired states of lipid

homeokinetic failure that make atherogenesis self‑sustaining, clinically

progressive, and potentially resistant to late corrective measures.

References

Anitschkow N. Experimental atherosclerosis in animals. In: Cowdry

EV, editor. Arteriosclerosis: A Survey of the Problem. New York:

Macmillan; 1933. p. 271–322.

Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868–

874.

Libby P. The changing landscape of atherosclerosis. Nature.

2021;592(7855):524–533.

Borén J, Williams KJ. The central role of arterial retention of

cholesterol‑rich apolipoprotein B–containing lipoproteins in the5. 6. pathogenesis  

of atherosclerosis: a triumph of simplicity. Curr Opin Lipidol. 2016;27(5):473–483.

Tabas I, García‑Cardeña G, Owens GK. Recent insights into the

cellular biology of atherosclerosis. J Cell Biol. 2015;209(1):13–22.

Steinberg D. The cholesterol controversy: past, present and future.

Atherosclerosis. 2005;181(1):1–8.